Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

The use of nitric oxide donors in pharmacological studies.

Feelisch M.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Jul;358(1):113-22. Review.

PMID:
9721012
2.

Various nitric oxide donors protect chick embryonic neurons from cyanide-induced apoptosis.

Jensen MS, Nyborg NC, Thomsen ES.

Toxicol Sci. 2000 Nov;58(1):127-34.

PMID:
11053549
3.

Chemical evaluation of compounds as nitric oxide or peroxynitrite donors using the reactions with serotonin.

Blanchard B, Servy C, Ducrocq C.

Free Radic Res. 2001 Feb;34(2):189-91.

PMID:
11264894
4.

Inhibition of cathepsin K by nitric oxide donors: evidence for the formation of mixed disulfides and a sulfenic acid.

Percival MD, Ouellet M, Campagnolo C, Claveau D, Li C.

Biochemistry. 1999 Oct 12;38(41):13574-83.

PMID:
10521264
5.

In vitro activation of soluble guanylyl cyclase and nitric oxide release: a comparison of NO donors and NO mimetics.

Artz JD, Toader V, Zavorin SI, Bennett BM, Thatcher GR.

Biochemistry. 2001 Aug 7;40(31):9256-64.

PMID:
11478893
6.

Nitric oxide inhibition of tobacco catalase and ascorbate peroxidase.

Clark D, Durner J, Navarre DA, Klessig DF.

Mol Plant Microbe Interact. 2000 Dec;13(12):1380-4.

7.

Neuroprotective properties of nitric oxide.

Chiueh CC.

Ann N Y Acad Sci. 1999;890:301-11. Review.

PMID:
10668435
8.

Comparative effects of various nitric oxide donors on ferritin regulation, programmed cell death, and cell redox state in plant cells.

Murgia I, de Pinto MC, Delledonne M, Soave C, De Gara L.

J Plant Physiol. 2004 Jul;161(7):777-83.

PMID:
15310066
9.

Accumulation of HIF-1alpha under the influence of nitric oxide.

Sandau KB, Fandrey J, BrĂ¼ne B.

Blood. 2001 Feb 15;97(4):1009-15.

10.

Biological chemistry and clinical potential of S-nitrosothiols.

Hogg N.

Free Radic Biol Med. 2000 May 15;28(10):1478-86. Review.

PMID:
10927172
11.

Nitric oxide inhibits falcipain, the Plasmodium falciparum trophozoite cysteine protease.

Venturini G, Colasanti M, Salvati L, Gradoni L, Ascenzi P.

Biochem Biophys Res Commun. 2000 Jan 7;267(1):190-3.

PMID:
10623597
12.

Metabolic regulation of aldose reductase activity by nitric oxide donors.

Dixit BL, Ramana KV, Chandra D, Jackson EB, Srivastava S, Bhatnagar A, Srivastava SK.

Chem Biol Interact. 2001 Jan 30;130-132(1-3):573-81.

PMID:
11306076
13.

Inactivation of ribonucleotide reductase by nitric oxide.

Lepoivre M, Fieschi F, Coves J, Thelander L, Fontecave M.

Biochem Biophys Res Commun. 1991 Aug 30;179(1):442-8.

PMID:
1652957
14.

Regulation of leukocyte function by nitric oxide donors: the effect of S-nitroso-thiol complexes.

Gluckman TL, Grossman JE, Folts JD, Kruse-Elliott KT.

J Toxicol Environ Health A. 2000 Sep 15;61(1):9-26.

PMID:
10990160
15.

Differential interactions of nitric oxide donors with rat oxyhemoglobin.

Tabrizi-Fard MA, Lee WI, Fung HL.

Biochem Pharmacol. 1999 Aug 15;58(4):671-4.

PMID:
10413305
16.
17.

Effects of nitric oxide donors on vascular endothelial growth factor gene induction.

Kimura H, Ogura T, Kurashima Y, Weisz A, Esumi H.

Biochem Biophys Res Commun. 2002 Aug 30;296(4):976-82.

PMID:
12200144
18.

Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.

Sogo N, Magid KS, Shaw CA, Webb DJ, Megson IL.

Biochem Biophys Res Commun. 2000 Dec 20;279(2):412-9.

PMID:
11118301
19.

Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.

Jurasz P, Sawicki G, Duszyk M, Sawicka J, Miranda C, Mayers I, Radomski MW.

Cancer Res. 2001 Jan 1;61(1):376-82.

20.

Activity of nitric oxide-generating compounds against encephalomyocarditis virus.

Guillemard E, Geniteau-Legendre M, Kergot R, Lemaire G, Petit JF, Labarre C, Quero AM.

Antimicrob Agents Chemother. 1996 Apr;40(4):1057-9.

Supplemental Content

Support Center